Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local mitomycin C for caustic esophageal stricture after endoscopic dilatation
IRCT20201116049399N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of mitomycin c in caustic esophageal stricture (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Dysphagia. Started Nov 2020; status: completed.
02
Drugs
mitomycin c
03
Conditions
caustic esophageal stricture
Beyond the preview
Go deeper on IRCT20201116049399N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201116049399N1.